Patrick Clinton

More consolidation didn't boost sales at the top, but a handful of nimble newcomers posted impressive growth on the other end of the curve.

In the long run, pharma wants to sell health, not just drugs.

FDA slaps down Cheerios and forces pharma companies that use Google to make technical changes no consumer will ever notice. Big whoop.

Our 3-D cover jumps off the page. But the real question for us (and for you) is how do we get everything else to connect?

Unsolicited advice for FDA's next leader: Keep it real, fight popular delusions, and somehow, please, defend the agency.

The worst thing about working for most corporations is the inevitable downward pull they exert even on the best of us. That's why it's always sad to lose a company that learned to fight back.

No one who cares about global health can be happy with a system that only "eventually" delivers drugs and vaccines for the planet's neediest people

It's just the way life works: You're always crossing the bridge before you get to it-or after it's gone

Two years ago, an internal Merck survey revealed that its basic research operation was "every flavor of what you don't want." Today the company is in the midst of implementing a new strategy that groups scientists at sites dedicated to particular clinical areas. VP Kathleen Metters explains why - and how.

Maybe what you're feeling isn't impending doom. Maybe it's just growing pains.